News - Hortons Pharmacy

New Treatments for Hidradenitis Suppurativa (HS) in Major Markets

Hidradenitis suppurativa (HS) is a chronic skin condition that causes painful lumps and abscesses, often in areas like the armpits […]

The U.S. Food and Drug Administration (FDA) has appointed Dr. George Tidmarsh as the new director of its Center for

Artificial intelligence (AI) is changing how healthcare and drug companies use real-world patient data. But simply using AI isn’t enough—it

Bristol Myers Squibb has named Dr. Cristian Massacesi as its new Executive Vice President and Chief Medical Officer, overseeing all

A new report predicts that the market for hidradenitis suppurativa (HS) treatments will grow significantly over the next decade, from

European drug regulators have recommended rejecting Elevidys, a gene therapy for Duchenne muscular dystrophy (DMD), in a setback for its

Astellas and Apellis are competing for market share in the U.S. for their geographic atrophy (GA) treatments, Izervay and Syfovre.

The pharmaceutical industry is highly competitive, which has led to a big increase in healthcare advertising, with spending expected to

Here’s a simplified version of the text: There’s a rare heart condition known as transthyretin amyloidosis cardiomyopathy that has caught

Earlier this year, EyePoint Pharmaceuticals faced doubts about its drug-device combo, Duravyu, after it failed in a study for nonproliferative